Inventor
ARET EDWIN
NL15 patents
⚠️ This page may combine multiple inventors who share the name “ARET EDWIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACERTA PHARMA BV
5 patentsUS9796721B2Oct 24, 2017
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
ACERTA PHARMA BV12 citations90
US10167291B2Jan 1, 2019
Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
ACERTA PHARMA BV1 citations71
US11820777B2Nov 21, 2023
Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
ACERTA PHARMA BV0 citations60
US11059829B2Jul 13, 2021
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide maleate
ACERTA PHARMA BV0 citations60
US10640509B2May 5, 2020
Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma
ACERTA PHARMA BV0 citations50
INTRA CELLULAR THERAPIES INC
4 patentsUS11014925B2May 25, 2021
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
INTRA CELLULAR THERAPIES INC26 citations93
US10654854B2May 19, 2020
Salts and crystals of ITI-007
INTRA CELLULAR THERAPIES INC32 citations93
US11440911B2Sep 13, 2022
Salts and crystals
INTRA CELLULAR THERAPIES INC11 citations85
US12384783B2Aug 12, 2025
Salts and crystals
INTRA CELLULAR THERAPIES INC0 citations62
KING S COLLEGE LONDON
2 patentsUS11584741B2Feb 21, 2023
Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation
KING S COLLEGE LONDON0 citations58
US10870644B2Dec 22, 2020
Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation
KING S COLLEGE LONDON1 citations56